Deaths with transdermal fentanyl patches

American Journal of Forensic Medicine and Pathology

Volumn 31, Issue 1, 2010, Pages 18-21

  Jumbelic, Mary I ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; BODY MASS; CASE REPORT; CHEMISTRY; FEMALE; FORENSIC TOXICOLOGY; HUMAN; INTOXICATION; INTRADERMAL DRUG ADMINISTRATION; LIVER; MALE; MIDDLE AGED; PRESCRIPTION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANALGESICS, OPIOID; BODY MASS INDEX; DRUG PRESCRIPTIONS; FEMALE; FENTANYL; FORENSIC TOXICOLOGY; HUMANS; LIVER; MALE; MIDDLE AGED; OVERDOSE; SUBSTANCE-RELATED DISORDERS;

EID: 77649224543     PISSN: 01957910     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAF.0b013e31818738b8     Document Type: Article

References (21)

1. Fentanyl briefs and background. Available at: http://www.usdoj.gov/dea/ concern/fentanylp.html. Accessed June 14, 2007.
2. Mylan Technologies Inc. Available at: http://www.mylantech.com/about-us/ history.aspx. Accessed June 14, 2007.
3. Pharmacy facts and figures. Available at: http://www.drugtopics.com/ drugtopics/ article/articleList.jsp?categoryId=7604. Accessed June 15, 2007.
4. Wyman J. Warning against misusing of fentanyl analgesic skin patch. Food and Drug Administration news release. January 18, 1994. Available at: http://www.fda.gov/bbs/topics/NEWS/NEW00459.html. Accessed June 14, 2007.
5. Anderson D, Muto J. Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol. 2000;24:627-634.
6. FDA public health advisory, safety warnings regarding use of fentanyl transdermal (skin) patches. Available at: http://www.fda.gov/cder/drug/ advisory/fentanyl.htm. Accessed June 14, 2007.
7. Janssen Pharmaceutica Products. Patient information, Duragesic (fentanyl transdermal system). Janssen 2003. Available at: http://www.fda.gov/cder/ drug/advisory/fentanyl.htm. Accessed June 14, 2007
8. Duragesic (fentanyl transdermal system). In: LaGow B, ed. Physicians Desk Reference. 61st ed. Montvale, NJ: Thomson PDR; 2007:2373-2379.
9. Henderson G. Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases. J Forensic S. 1991;36:422-433.
10. SAMHSA drug information: fentanyl. Available at: http://www.samhsa.gov/ drugalerts/fentanyl-july06.aspx. Accessed June 14, 2007.
11. Ripple M, Levine B, Jufer-Phipps R, et al. Cluster of fentanyl-tainted heroin deaths in a three-week period in Maryland. In: Proceedings of the American Academy of Forensic Sciences. Annual Meeting; February 19-24, 2007; San Antonio, TX.
12. Denton J, Donoghue E, Kalelkar M, et al. "Drop dead": an epidemic of intravenous fentanyl deaths in Cook County, Illinois: 2005 to present. In: Proceedings of the American Academy of Forensic Sciences. Annual Meeting; February 19-24, 2007; San Antonio, TX.
13. Thorpe L, Harrison M. 2006 NYC DOHMH health alert #31: at least 16 fentanyl-related. New York County Medical Society. August 25, 2006. Available at: http://www.nycms.org/article-view.php3?view=1386&art= 1. Accessed on June 14, 2007.
14. Edinboro L, Poklis A, Trautman D, et al. Fatal fentanyl intoxication following excessive transdermal application. J Forensic Sci. 1997;42:741-743.
15. Martin TL, Woodall KL, McLellan BA. Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004). J Anal Toxicol. 2006;30:603-610.
16. Transdermal fentanyl (Duragesic): respiratory arrest in adolescents. Canadian adverse reaction newsletter 2004;14. Available at: http://www.hc-sc.gc. ca/ dhp-mps/medeff/bulletin/carn-bcei-v14n4-e.html. Accessed June 15 2007.
17. Duragesic (fentanyl transdermal system CII) recall notice. Available at: http://www.fda.gov/medwatch/SAFETY/2004/duragesic.htm. Accessed June 14, 2007.
18. Product recalls Australia. Available at: http://www.recalls.gov.au/view- recall-detail.php?Recall-ID-Auto = 13704. Accessed June 14, 2007.
19. Cooklock K, Dreyer S, Hart J, et al. Cross migration of excipients between transdermal patches. Presented at: American Association of Pharmaceutical Scientists. 3M Pharmaceuticals; October 27-31, 1996.
20. Drugs and supplements, fentanyl, in Medline Plus. Available at: http://www/ nlm.nih.gov/medlineplus/druginfo/uspdi/203780.html. Accessed on December 5, 2006.
21. Report from the committee on drug safety. In: The Future of Drug Safety: Promoting and Protecting the Health of the Public. Institute of Medicine, National Academy of Sciences. September 22, 2006.